M
1.10
-0.04 (-3.93%)
| Previous Close | 1.15 |
| Open | 1.10 |
| Volume | 2,173 |
| Avg. Volume (3M) | 12,336 |
| Market Cap | 18,997,038 |
| Price / Sales | 0.330 |
| Price / Book | 1.49 |
| 52 Weeks Range | |
| Earnings Date | 11 Nov 2025 |
| Profit Margin | -79.41% |
| Operating Margin (TTM) | -41.53% |
| Diluted EPS (TTM) | -2.92 |
| Quarterly Revenue Growth (YOY) | -26.60% |
| Current Ratio (MRQ) | 0.650 |
| Operating Cash Flow (TTM) | -11.69 M |
| Levered Free Cash Flow (TTM) | -5.19 M |
| Return on Assets (TTM) | -34.14% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bullish | Mixed |
| Healthcare Plans (Global) | Bullish | Mixed | |
| Stock | Marpai, Inc. | Mixed | Mixed |
AIStockmoo Score
1.6
| Analyst Consensus | 2.0 |
| Insider Activity | 3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 4.0 |
| Average | 1.60 |
|
Marpai Inc operates as a health plan company. It uses A.I. to predict and help prevent costly events for its members, and in turn, lower its clients’ health care costs. It offers a health plan services system that addresses the problems of healthcare past and enables companies to provide healthcare to employees. The company generates the majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Small Value |
| % Held by Insiders | 58.39% |
| % Held by Institutions | 12.40% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| LAMENDOLA DAMIEN | 1.36 | - | 147,058 | 199,999 |
| Aggregate Net Quantity | 147,058 | |||
| Aggregate Net Value ($) | 199,999 | |||
| Aggregate Avg. Buy ($) | 1.36 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LAMENDOLA DAMIEN | Officer | 30 Sep 2025 | Buy (+) | 147,058 | 1.36 | 199,999 |
| Date | Type | Details |
|---|---|---|
| 06 Oct 2025 | Announcement | MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND |
| 13 Aug 2025 | Announcement | MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS |
| 07 Aug 2025 | Announcement | MARPAI TO HOST WEBCAST ON AUGUST 14, 2025 TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS |
| 24 Jul 2025 | Announcement | MARPAIRX REVOLUTIONIZES PHARMACY BENEFITS WITH UNPRECEDENTED TRANSPARENCY AND SAVINGS |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |